BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 226 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,359,786 | -13.7% | 98,120 | +14.6% | 0.00% | 0.0% |
| Q2 2023 | $2,734,772 | +49.9% | 85,649 | +43.8% | 0.00% | 0.0% |
| Q1 2023 | $1,824,125 | +181.7% | 59,573 | +259.8% | 0.00% | – |
| Q4 2022 | $647,622 | -35.2% | 16,559 | -21.2% | 0.00% | – |
| Q3 2022 | $1,000,000 | -65.6% | 21,007 | -72.0% | 0.00% | -100.0% |
| Q2 2022 | $2,904,000 | -43.4% | 75,024 | -16.2% | 0.00% | 0.0% |
| Q1 2022 | $5,131,000 | -2.6% | 89,529 | +35.4% | 0.00% | 0.0% |
| Q4 2021 | $5,269,000 | +10.5% | 66,123 | +20.7% | 0.00% | 0.0% |
| Q3 2021 | $4,767,000 | -36.4% | 54,787 | -6.0% | 0.00% | -50.0% |
| Q2 2021 | $7,500,000 | +105.3% | 58,270 | +27.7% | 0.00% | +100.0% |
| Q1 2021 | $3,653,000 | +17.1% | 45,634 | +19.5% | 0.00% | 0.0% |
| Q4 2020 | $3,119,000 | +283.2% | 38,202 | +15.6% | 0.00% | – |
| Q3 2020 | $814,000 | +100.0% | 33,051 | +127.3% | 0.00% | – |
| Q2 2020 | $407,000 | +186.6% | 14,543 | +84.0% | 0.00% | – |
| Q1 2020 | $142,000 | – | 7,903 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |